---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-007314"
form_type: "8-K"
ticker: "HSCS"
cik: "0001468492"
company_name: "HeartSciences Inc."
filed_at: "2025-01-21T23:59:59+00:00"
generated_at: "2026-05-27T22:03:32.473368+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# HeartSciences grants 117K options to execs and directors at $3.33 strike

## Summary
- CEO Andrew Simpson and COO Mark Hilz each receive 45,000 options; CFO Danielle Watson receives 9,000.
- Non-employee directors Brian Szymczak, Bruce Brent, and David R. Wells each receive 6,000 options.
- All options have exercise price of $3.33 per share; executive options vest over 3 years with 1-year cliff.
- Director options vested 1/4 immediately, remainder quarterly; vesting may accelerate on FDA clearance.

## SEC filing metadata
- accession: 0000950170-25-007314
- form_type: 8-K
- ticker: HSCS
- cik: 0001468492
- company_name: HeartSciences Inc.
- filed_at: 2025-01-21T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 3.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468492/000095017025007314/0000950170-25-007314-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468492/000095017025007314/hscs-20250116.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-007314
- JSON: https://secwatch.observer/filing/0000950170-25-007314.json
- Plain text: https://secwatch.observer/filing/0000950170-25-007314.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.